JP2016520603A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520603A5
JP2016520603A5 JP2016516143A JP2016516143A JP2016520603A5 JP 2016520603 A5 JP2016520603 A5 JP 2016520603A5 JP 2016516143 A JP2016516143 A JP 2016516143A JP 2016516143 A JP2016516143 A JP 2016516143A JP 2016520603 A5 JP2016520603 A5 JP 2016520603A5
Authority
JP
Japan
Prior art keywords
composition
rutin
composition according
curcumin
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016516143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520603A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/061022 external-priority patent/WO2014191448A1/en
Publication of JP2016520603A publication Critical patent/JP2016520603A/ja
Publication of JP2016520603A5 publication Critical patent/JP2016520603A5/ja
Pending legal-status Critical Current

Links

JP2016516143A 2013-05-29 2014-05-28 軟骨破壊における使用のための組成物 Pending JP2016520603A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13169653 2013-05-29
EP13169653.6 2013-05-29
PCT/EP2014/061022 WO2014191448A1 (en) 2013-05-29 2014-05-28 Compositions for use in cartilage breakdown

Publications (2)

Publication Number Publication Date
JP2016520603A JP2016520603A (ja) 2016-07-14
JP2016520603A5 true JP2016520603A5 (https=) 2017-07-06

Family

ID=48485058

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016516143A Pending JP2016520603A (ja) 2013-05-29 2014-05-28 軟骨破壊における使用のための組成物

Country Status (8)

Country Link
US (1) US20160101125A1 (https=)
EP (1) EP3003338A1 (https=)
JP (1) JP2016520603A (https=)
CN (1) CN105246499A (https=)
AU (1) AU2014273186A1 (https=)
BR (1) BR112015029354A2 (https=)
CA (1) CA2913621A1 (https=)
WO (1) WO2014191448A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015029611B1 (pt) * 2013-05-29 2023-01-17 Société Des Produits Nestlé S.A Uso de uma composição compreendendo oleuropeína
WO2019092066A1 (en) * 2017-11-08 2019-05-16 Nestec S.A. Method of selecting a probiotic
JP7304346B2 (ja) * 2017-11-08 2023-07-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ホモバニリルアルコール（ｈｖａ）、ｈｖａ異性体、このような化合物を含む組成物の作製方法、及びこのような化合物を使用する方法
CN111315386A (zh) * 2017-11-08 2020-06-19 雀巢产品有限公司 橄榄苦苷的生物转化
EP3706758B1 (en) * 2017-11-08 2022-06-29 Société des Produits Nestlé S.A. Bioconversion of oleuropein
CN108686119A (zh) * 2018-06-27 2018-10-23 陶燃 一种治疗痛风的药物组合物及其应用
CA3147400A1 (en) * 2019-08-02 2021-02-11 Suntory Holdings Limited Composition for cartilage regeneration promotion
AU2020406604A1 (en) * 2019-12-17 2022-07-07 Suntory Holdings Limited Composition for promoting chondroitin sulfate synthesis
KR20220123074A (ko) * 2020-02-28 2022-09-05 바이오서치 에스.에이. 히드록시티로솔의 경구 생체 이용률 개선을 위한 폴리페놀계 조성물 및 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
US20040219240A1 (en) * 2001-06-20 2004-11-04 Babish John G. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
JP4592249B2 (ja) * 2001-11-30 2010-12-01 江崎グリコ株式会社 リウマチの症状改善用飲食品および医薬
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
WO2007094827A2 (en) * 2006-02-10 2007-08-23 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
EP2040696B1 (en) * 2006-07-14 2017-01-25 DSM IP Assets B.V. Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
US7871609B2 (en) * 2007-03-02 2011-01-18 Sam Ziff Supplements for pain management
CA2623733A1 (en) * 2007-03-02 2008-09-02 Sam Ziff Supplements for pain management
NZ579340A (en) * 2007-03-19 2012-05-25 Metaproteomics Llc Methods and compositions for promoting bone and joint health comprising berberine
EP2229940B1 (en) * 2009-03-20 2015-07-01 Bioxtract S.A. Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
BR112015029611B1 (pt) * 2013-05-29 2023-01-17 Société Des Produits Nestlé S.A Uso de uma composição compreendendo oleuropeína

Similar Documents

Publication Publication Date Title
JP2016520603A5 (https=)
NZ731248A (en) Cannabis extracts and methods of preparing and using same
BR112012026758A2 (pt) cápsula, método para produzir cápsulas com uma estrutura de núcleo/envoltório, usos de cápsulas com uma estrutura de núcleo/envoltório, e de preparações pulverulentas ou líquidas, e, composição farmacêutica, de cosméticos, preparação de proteção de cultura, alimentação de animal, suplemento alimetar ou nutricional
AR056081A1 (es) Composicion que es posible de dispersar en agua y metodo para prepararla
CL2015003545A1 (es) Una capsula para preparar composiciones comestibles
BR112017003346B8 (pt) Derivados de pirazolopiridina, seus usos, e composição farmacêutica
MX2014003364A (es) Formulaciones nutricionales en polvo que incluyen proteina vegetal secada por aspersion.
WO2011036316A3 (es) Uso de extractos vegetales como prebióticos, composiciones y alimentos que los contienen
NO20075540L (no) Lignian-inneholdende sammensetninger
WO2011059292A3 (ko) 피부세포증식 촉진, 항산화 및 항알러지 효과가 우수한 알로에 베라 새순 농축물 또는 추출물
MX2019004901A (es) Extracto de una composicion herbal como agente antimicrobiano y/o antibiopelicula.
MX387386B (es) Sistema de alimentacion para mascotas.
PT3279210T (pt) Péptido com atividade anticancerígena, composição farmacêutica e composição de suplementos alimentares para prevenção e tratamento do cancro, ambos os quais contêm o mesmo ingrediente ativo
MX2018004796A (es) Conservacion de vitaminas hidrosolubles.
WO2012050398A3 (ko) 생약 추출물을 포함하는 폐암 예방 또는 치료용 약학적 조성물
MX2010009314A (es) Polifenoles para el tratamiento de padecimientos de cartilago.
WO2012050397A3 (ko) 생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물
CL2012002893A1 (es) Composición de al menos un ingrediente activo de origen vegetal o sintético análogo del mismo, o extracto de origen vegetal que lo contiene, en una solución acuosa, que además comprende lecitina como agente encapsulante; medicamento que la comprende; método para su preparación; y su uso para tratar parasitosis intestinales.
BR112013013908A2 (pt) produtos alimentícios para crianças compreendendo grãos integrais hidrolisados
BR112013002832A2 (pt) composição compreendendo retinol, um precursor ou um produto de reação do mesmo e um extrato vegetal de pelo menos uma planta de camomila para o tratamento de câncer
AR101673A1 (es) Composición para el tratamiento de neuropatías y del dolor neuropático
CL2017001472A1 (es) Composiciones y métodos que comprenden triglicéridos de cadena media para el tratamiento de la epilepsia.
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2008126367A1 (ja) 精神安定剤および機能性食品
AR093103A1 (es) COMPOSICION A BASE DE HIERBAS PARA LA PREVENCION Y TRATAMIENTO DE FACTOR a DE NECROSIS TUMORAL (TNF-a) UNA ENFERMEDAD MEDIADA